Severe Neutropenia and Esophagitis Associated With Avelumab for Urothelial Carcinoma: A Case Report.

Authors

Takayuki Hirano, Takashi Kawahara, Yuta Karibe, Genta Iwamoto, Jun Asano, Shusei Fusayasu, Nobuhiko Mizuno, Kazuhide Makiyama, Hiroji Uemura, Masatoshi Moriyama, Junichi Ohta

Published in

Clinical case reports. Volume 14. Issue 7. Pages e73086. Epub Jul 02, 2026.

Abstract

Bladder cancer prognosis varies with invasiveness, requiring treatments like surgery or chemotherapy. Immune checkpoint inhibitors, such as Avelumab, are standard for advanced cases but can cause side effects like neutropenia and esophagitis, as seen in a reported case during Avelumab maintenance therapy.

PMID:
42404671
Bibliographic data and abstract were imported from PubMed on 06 Jul 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.